1,618.94 EBITDA -386.67 -263.82 403.48 511.73 Depre. & Amor. 174.68 180.44 164.35 177.19 EBIT -561.35 -444.27 239.13 334.53 Net Profit : Owners Of The Parent -918.09 -655.61 57.26 148.96 EPS (B.) -0.32 -0.23
Selling And Administrative Expenses 1,208.25 1,093.54 1,100.09 1,023.93 Total Cost And Expenses 4,660.90 4,152.15 4,519.72 4,658.42 EBITDA 752.85 637.63 542.31 665.63 Depre. & Amor. 289.82 295.77 233.85
Expenses 698.08 749.08 1,111.68 1,218.77 Total Cost And Expenses 3,440.49 3,708.14 4,898.15 5,151.63 EBITDA 385.67 474.05 562.40 666.56 Depre. & Amor. 181.68 182.92 163.21 123.03 EBIT 203.99 291.14 399.19
9,819.12 7,676.37 EBITDA 1,418.27 332.13 1,854.02 -4,027.64 3,491.67 Depre. & Amor. 274.10 505.61 913.79 1,697.59 730.85 EBIT 1,144.17 -173.48 940.23 -5,725.23 2,760.81 Net Profit : Owners Of The Parent
in 2Q18. This was mostly due to an increase in revenues from Inpatients, Outpatients and IVF patients. The Company reported Cost of Hospital Operations (including Depreciation and Amortization) of Baht
in 3Q17. This was mostly due to an increase in revenues from Inpatients, Outpatients and IVF patients. The Company reported Cost of Hospital Operations (including Depreciation and Amortization) of Baht
Depreciation and Amortization) of Baht 137.74 million or 34.26% increase year-over-year from Baht 102.59 million in 3Q18. This represents an increase in the cost of doctors, nurses, drugs, medical supplies and
and Outpatients. The Company reported Cost of Hospital Operations including Depreciation and Amortization of Thai Baht 509.33 million in 2019, or 33.28% increase year-over-year from Baht 382.14 million
. Centers operating distinctive income included Pediatrics Center and Emergency Center. The Company reported Cost of Hospital Operations (including Depreciation and Amortization) of Baht 109.59 million for
well as attending Chinese fertility centers which is the main user group of the subsidiary company. The Company reported Cost of Hospital Operations (including Depreciation and Amortization) of THB